लोड हो रहा है…
हमारे कवर किए 50 कंपनियाँ, जिनमें से 48 ग्रेडेड
यहाँ हर कंपनी वृद्धि और नकदी बनाने की उन्हीं पाँच जाँचों से गुज़री है। यह उद्योग का वह वर्णन है जैसा वह आज बताता है — यह नहीं कि इनमें से क्या खरीदा जाए।
| ISRG | Intuitive Surgical, Inc. | A+ | $143.1B | $405.18 | 46.47 | $11B | 28.4% |
| BDX | BECTON, DICKINSON AND COMPANY | B | $50.1B | $183.82 | 55.37 | $23.3B | 4.0% |
| RMD | ResMed Inc. | B+ | $32B | $222.00 | 21.28 | $5.7B | 26.9% |
| ALC | Alcon Inc. | B | $31.4B | $64.47 | 32.56 | $9.5B | 10.3% |
| MDLN | Medline Inc. | C | $29.2B | $34.70 | 24.25 | $28.4B | 4.1% |
| WST | WEST PHARMACEUTICAL SERVICES, INC. | B+ | $26.1B | $370.44 | 47.43 | $3.3B | 17.0% |
| SOLV | SOLVENTUM CORPORATION | F+ | $15.2B | $89.50 | 10.95 | $8.3B | 17.3% |
| BAX | BAXTER INTERNATIONAL INC. | D- | $12.1B | $23.37 | — | $11.5B | -9.3% |
| RGEN | REPLIGEN CORP | A | $10.7B | $189.68 | 259.84 | $785.1M | 5.3% |
| COO | The Cooper Companies, Inc. | A | $10.5B | $55.38 | 18.97 | $4.2B | 13.5% |
| ALGN | ALIGN TECHNOLOGY, INC. | A | $10.4B | $146.78 | 25.57 | $4.1B | 10.0% |
| AVTR | Avantor, Inc. | F | $10.4B | $15.25 | — | $6.6B | -8.4% |
| ATR | AptarGroup, Inc | A | $7.9B | $123.87 | 22.36 | $3.9B | 9.2% |
| STVN | Stevanato Group S.p.A. | C | $6.4B | $21.13 | 36.41 | $1.4B | 11.0% |
| BLCO | Bausch & Lomb Corp | A- | $6B | $16.86 | — | $5.3B | -3.2% |
| MMED | MiniMed Group, Inc. | D- | $5.6B | $19.98 | — | $3.1B | -10.0% |
| MMSI | MERIT MEDICAL SYSTEMS INC | B | $5.2B | $87.50 | 36.01 | $1.6B | 9.2% |
| TFX | TELEFLEX INCORPORATED | C | $5.2B | $122.07 | — | $2.3B | -45.8% |
| ICUI | ICU MEDICAL INC/DE | C | $4.1B | $164.95 | 138.61 | $2.2B | 0.0% |
| NVST | ENVISTA HOLDINGS CORPORATION | A | $3.8B | $23.95 | 41.29 | $2.9B | 3.3% |
| PLSE | Pulse Biosciences, Inc. | D- | $3.7B | $51.63 | — | $1.2M | -6,755.8% |
| WRBY | Warby Parker Inc. | B | $3.4B | $26.71 | 381.57 | $911.6M | 0.8% |
| ATRC | AtriCure, Inc. | A | $3B | $58.38 | 278.00 | $569.6M | 1.9% |
| BLFS | BioLife Solutions, Inc. | A+ | $1.9B | $38.49 | 32.90 | $102.8M | 56.4% |
| XRAY | DENTSPLY SIRONA Inc. | D- | $1.9B | $9.40 | — | $3.6B | -15.0% |
| LMAT | LEMAITRE VASCULAR, INC. | B+ | $1.9B | $81.52 | 28.60 | $262.4M | 25.0% |
| KMTS | Kestra Medical Technologies, Ltd. | D- | $1.6B | $27.14 | — | $106.7M | -140.4% |
| AZTA | AZENTA, INC. | C- | $1.5B | $34.02 | — | $613.8M | -20.0% |
| STAA | STAAR Surgical Co | C | $1B | $20.51 | 256.38 | $339.6M | 1.1% |
| ANGO | AngioDynamics, Inc. | B- | $640.2M | $15.49 | — | $320.2M | -11.5% |
| EMBC | EMBECTA CORP. | D | $334.3M | $5.90 | 4.01 | $1B | 8.6% |
| SMTI | SANARA MEDTECH INC. | A- | $322.1M | $35.06 | — | $109.8M | -29.2% |
| ZJYL | Jin Medical International Ltd. | F | $299M | $1.91 | 191.00 | $20.7M | 5.8% |
| NNNN | Anbio Biotechnology | B+ | $275.1M | $6.30 | 42.86 | $8.6M | 74.1% |
| OSUR | ORASURE TECHNOLOGIES, INC | F- | $271M | $3.93 | — | $112.4M | -43.7% |
| UTMD | UTAH MEDICAL PRODUCTS, INC. | F+ | $236.2M | $74.18 | 22.62 | $36.1M | 29.0% |
| PDEX | PRO-DEX, INC. | A+ | $229.9M | $71.77 | 17.46 | $77.5M | 17.6% |
| KRMD | KORU MEDICAL SYSTEMS, INC. | A- | $148.2M | $3.21 | — | $45.1M | -4.0% |
| STXS | STEREOTAXIS, INC. | F- | $130.3M | $1.30 | — | $30.1M | -74.2% |
| POCI | PRECISION OPTICS CORPORATION, INC. | D- | $50.7M | $4.63 | — | $28.9M | -17.0% |
| DXR | Daxor Corporation | ग्रेड नहीं | $46.2M | $11.01 | — | $1.4M | -496.8% |
| NEPH | NEPHROS, INC. | C | $45.9M | $4.23 | 26.44 | $20.7M | 8.4% |
| MLSS | MILESTONE SCIENTIFIC INC. | C- | $36.4M | $0.41 | — | $9.4M | -44.0% |
| HBIO | HARVARD BIOSCIENCE, INC. | F- | $36.2M | $7.96 | — | $87.8M | -11.9% |
| RVP | RETRACTABLE TECHNOLOGIES INC | F- | $21M | $0.70 | — | $33.9M | -9.9% |
| BNGO | Bionano Genomics, Inc. | D- | $19.5M | $1.66 | — | $30.2M | -106.6% |
| FEMY | Femasys Inc. | C- | $8.3M | $2.48 | — | $2.3M | -511.8% |
| CUPR | Cuprina Holdings (Cayman) Limited | F- | $4.8M | $1.87 | — | $39K | -9,366.8% |
| NXGL | NEXGEL, INC. | B- | $1.7M | $0.17 | — | $12.1M | -51.3% |
| RGNT | Regentis Biomaterials Ltd. | ग्रेड नहीं | $1.1M | $1.98 | 1.15 | — | — |
मूल आँकड़े SEC रिपोर्टों से, भाव अंतिम बाज़ार-डेटा पास से। किसी भी स्तंभ से क्रम दें; जिन कंपनियों का आँकड़ा नहीं है वे दोनों दिशाओं में अंत में जाती हैं।
बाज़ार मूल्य के अनुसार क्रमित, सबसे बड़ी पहले; फिर से क्रम देने के लिए किसी भी स्तंभ पर क्लिक करें। जिन कंपनियों का आँकड़ा नहीं है वे दोनों दिशाओं में अंत में जाती हैं, क्योंकि P/E का न होना सस्ता होना नहीं, घाटे में होना बताता है। यहाँ कुछ भी सिफ़ारिश नहीं है।